Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Extremely rapid hydroxylation of debrisoquine: a case report with implication for treatment with nortriptyline and other tricyclic antidepressants.

× No keyword cloud information.

29 in total

Review 1. Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs.

Authors: Leif Bertilsson; Marja-Liisa Dahl; Per Dalén; Ayman Al-Shurbaji
Journal: Br J Clin Pharmacol Date: 2002-02 Impact factor: 4.335

2. Monitoring tricyclic antidepressant therapy.

Authors: M V Rudorfer
Journal: Pharmacoeconomics Date: 1992-02 Impact factor: 4.981

Review 3. The impact of the CYP2D6-polymorphism on dose recommendations for current antidepressants.

Authors: Norbert Thuerauf; Jens Lunkenheimer
Journal: Eur Arch Psychiatry Clin Neurosci Date: 2006-08 Impact factor: 5.270

Review 4. The AmpliChip CYP450 genotyping test: Integrating a new clinical tool.

Authors: Jose de Leon; Margaret T Susce; Elaina Murray-Carmichael
Journal: Mol Diagn Ther Date: 2006 Impact factor: 4.074

Review 5. Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilance.

Authors: Eveline Jaquenoud Sirot; Jan Willem van der Velden; Katharina Rentsch; Chin B Eap; Pierre Baumann
Journal: Drug Saf Date: 2006 Impact factor: 5.606

6. Relationship between plasma desipramine levels, CYP2D6 phenotype and clinical response to desipramine: a prospective study.

Authors: E Spina; C Gitto; A Avenoso; G M Campo; A P Caputi; E Perucca
Journal: Eur J Clin Pharmacol Date: 1997 Impact factor: 2.953

Extremely rapid hydroxylation of debrisoquine: a case report with implication for treatment with nortriptyline and other tricyclic antidepressants.

Review 1. Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs.

2. Monitoring tricyclic antidepressant therapy.

Review 3. The impact of the CYP2D6-polymorphism on dose recommendations for current antidepressants.

Review 4. The AmpliChip CYP450 genotyping test: Integrating a new clinical tool.

Review 5. Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilance.

6. Relationship between plasma desipramine levels, CYP2D6 phenotype and clinical response to desipramine: a prospective study.

Review 7. The Role of Metabolites of Antidepressants in the Treatment of Depression.

8. Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II.

9. A convenient five-drug cocktail for the assessment of major drug metabolizing enzymes: a pilot study.

10. Oxidative polymorphism of dextromethorphan in a Burundi population.